We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$288M
AUM Growth
+$8.27M
Cap. Flow
-$14.5M
Cap. Flow %
-5.04%
Top 10 Hldgs %
36.46%
Holding
198
New
14
Increased
33
Reduced
121
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 22.19%
2 Technology 14.37%
3 Financials 12.04%
4 Industrials 9.07%
5 Communication Services 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCSH icon
26
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.54M 0.88%
33,822
-3,114
-8% -$233K
VTIP icon
27
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$2.5M 0.87%
53,435
+33,085
+163% +$1.58M
DGX icon
28
Quest Diagnostics
DGX
$25.9B
$2.49M 0.87%
15,927
-1,740
-10% -$250K
PG icon
29
Procter & Gamble
PG
$335B
$2.46M 0.85%
16,247
-846
-5% -$119K
AMZN icon
30
Amazon
AMZN
$2.9T
$2.35M 0.82%
28,024
+482
+2% +$47.6K
LIN icon
31
Linde
LIN
$221B
$2.32M 0.8%
7,104
-90
-1% -$28.2K
WMT icon
32
Walmart Inc
WMT
$888B
$2.27M 0.79%
48,018
-4,500
-9% -$214K
AMGN icon
33
Amgen
AMGN
$207B
$2.25M 0.78%
8,553
-1,100
-11% -$295K
BDX icon
34
Becton Dickinson
BDX
$45.4B
$2.22M 0.77%
8,743
+650
+8% +$153K
MGV icon
35
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$2.21M 0.77%
21,531
-401
-2% -$40.3K
TECH icon
36
Bio-Techne
TECH
$11.2B
$2.21M 0.77%
26,612
-1,580
-6% -$125K
CNC icon
37
Centene
CNC
$30.6B
$2.2M 0.76%
26,854
-925
-3% -$75.6K
CVS icon
38
CVS Health
CVS
$134B
$2.12M 0.73%
22,716
-422
-2% -$40.7K
INTC icon
39
Intel
INTC
$463B
$2.07M 0.72%
78,240
-5,588
-7% -$155K
VBR icon
40
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$2.01M 0.7%
12,656
+15
+0.1% +$2.39K
MTB icon
41
M&T Bank
MTB
$35.9B
$1.99M 0.69%
13,750
-1,096
-7% -$180K
WIA
42
Western Asset Inflation-Linked Income Fund
WIA
$184M
$1.99M 0.69%
231,321
-22,055
-9% -$195K
UNP icon
43
Union Pacific
UNP
$174B
$1.97M 0.68%
9,500
+115
+1% +$23.6K
GILD icon
44
Gilead Sciences
GILD
$162B
$1.86M 0.64%
21,629
-7,982
-27% -$632K
KO icon
45
Coca-Cola
KO
$377B
$1.85M 0.64%
29,077
-1,280
-4% -$77.3K
VIG icon
46
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.83M 0.63%
12,038
-20
-0.2% -$2.98K
BAB icon
47
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$1.72M 0.6%
66,943
-27,016
-29% -$692K
ANET icon
48
Arista Networks
ANET
$225B
$1.71M 0.59%
56,280
-31,160
-36% -$959K
MOAT icon
49
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$1.66M 0.58%
25,637
+3
+0% +$195
CHRW icon
50
C.H. Robinson
CHRW
$17.7B
$1.65M 0.57%
18,060
-335
-2% -$31.9K

Similar funds

Roberts, Glore & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Roberts, Glore & Co held 198 positions worth $288M, up 3% from $280M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Roberts, Glore & Co withdrew a net $14.5M in Q4 2022, closing 4 positions and reducing 121 holdings. Its most notable exit was C3.ai, an estimated $287K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Roberts, Glore & Co opened a new position in iShares MSCI EAFE ETF worth $1.06M.

  • Roberts, Glore & Co's largest Q4 2022 buy was iShares MSCI EAFE ETF: 16,096 shares worth $1.06M.
  • Roberts, Glore & Co added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q4 2022, an estimated $1.58M increase.
  • Roberts, Glore & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $1.35M.
  • Roberts, Glore & Co fully exited C3.ai in Q4 2022, selling an estimated $287K.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $288M portfolio in Q4 2022.
  • Roberts, Glore & Co opened 14 new positions and closed 4 in Q4 2022.
  • Roberts, Glore & Co's portfolio value rose 3% quarter-over-quarter to $288M.

Based on Roberts, Glore & Co's 13F filing for Q4 2022, filed 13 Feb 2023.